VRSK vs TEVA Comparison

Verisk Analytics is a leading provider of data analytics and proprietary solutions supporting clients within the insurance ecosystem. Verisk operates under a single segment with two separate business units, underwriting and claims. Within underwriting, the company operates as both a statistical agent and advisory organization collecting and aggregating industrywide claims and policy data and providing insurers with pre-approved forms, rules, and loss costs. Aside from their regulatory and compliance offerings, Verisk provides specialized solutions utilized to power P&C underwriting and catastrophe risk assessment used in reinsurance and insurance-linked securities. Verisk's smaller claims business is critical in preventing fraud and estimating property insurance claims.

Teva Pharmaceutical, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.